Features Editor
Spectrum
Ingrid Wickelgren edits Deep Dives, Spectrum’s long-form stories on important topics in autism research.
Before joining the foundation in 2015, Ingrid was senior editor at Scientific American Mind and wrote the Streams of Consciousness blog for ScientificAmerican.com. She has also authored three popular science books and has written for Science, Discover, Health and The New York Times.
Ingrid has a B.S. in biological sciences from Stanford University.
An electrical brain implant all but erased the obsessions that had consumed Becky Audette, years after her autism diagnosis. Could similar implants help other people with severe autism?
Scientists dish about the biggest challenges they face as they tackle tough questions about autism.
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
An analysis of blood samples from nearly 17,000 individuals with autism points to new regions of the genome likely to be involved in the disorder.
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.